Birgitte Volck - 31 Jan 2022 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Director
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
31 Jan 2022
Net transactions value
+$12,750
Form type
4
Filing time
02 Feb 2022, 19:29:25 UTC
Previous filing
02 Nov 2021
Next filing
14 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $12,750 +35,915 +51% $0.3550 105,678 31 Jan 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of SLNO common stock. The RSUs are fully vested on January 31, 2022.